Article Versions Notes

Jiang Y, Cheng X, Zhao M, Zhao T, Zhang M, Shi Z, Yue X, Geng Y, Gao J, Wang C, et al. Gypenoside-14 Reduces Depression via Downregulation of the Nuclear Factor Kappa B (NF-kB) Signaling Pathway on the Lipopolysaccharide (LPS)-Induced Depression Model. Pharmaceuticals. 2023; 16(8):1152. https://doi.org/10.3390/ph16081152

Jiang, Yaqun, Xiang Cheng, Ming Zhao, Tong Zhao, Mengya Zhang, Zibi Shi, Xiangpei Yue, Yanan Geng, Jiayue Gao, Chengbo Wang, and et al. 2023. "Gypenoside-14 Reduces Depression via Downregulation of the Nuclear Factor Kappa B (NF-kB) Signaling Pathway on the Lipopolysaccharide (LPS)-Induced Depression Model" Pharmaceuticals 16, no. 8: 1152. https://doi.org/10.3390/ph16081152

Jiang, Y., Cheng, X., Zhao, M., Zhao, T., Zhang, M., Shi, Z., Yue, X., Geng, Y., Gao, J., Wang, C., Yang, J., & Zhu, L. (2023). Gypenoside-14 Reduces Depression via Downregulation of the Nuclear Factor Kappa B (NF-kB) Signaling Pathway on the Lipopolysaccharide (LPS)-Induced Depression Model. Pharmaceuticals, 16(8), 1152. https://doi.org/10.3390/ph16081152